These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19480919)

  • 1. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC; Rosenkilde MM
    Methods Enzymol; 2009; 461():171-90. PubMed ID: 19480919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI.
    Rosenkilde MM; Andersen MB; Nygaard R; Frimurer TM; Schwartz TW
    Mol Pharmacol; 2007 Mar; 71(3):930-41. PubMed ID: 17170198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
    Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
    Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.
    Rummel PC; Thiele S; Hansen LS; Petersen TP; Sparre-Ulrich AH; Ulven T; Rosenkilde MM
    Mol Pharmacol; 2013 Sep; 84(3):335-45. PubMed ID: 23765404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships and identification of optmized CC-chemokine receptor CCR1, 5, and 8 metal-ion chelators.
    Chalikiopoulos A; Thiele S; Malmgaard-Clausen M; Rydberg P; Isberg V; Ulven T; Frimurer TM; Rosenkilde MM; Gloriam DE
    J Chem Inf Model; 2013 Nov; 53(11):2863-73. PubMed ID: 24083637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
    Rosenkilde MM
    Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?
    Wise E; Pease JE
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):755-9. PubMed ID: 17635141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding and micro-switches in 7TM receptor structures.
    Nygaard R; Frimurer TM; Holst B; Rosenkilde MM; Schwartz TW
    Trends Pharmacol Sci; 2009 May; 30(5):249-59. PubMed ID: 19375807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor oligomerization: functional considerations.
    Thelen M; Muñoz LM; Rodríguez-Frade JM; Mellado M
    Curr Opin Pharmacol; 2010 Feb; 10(1):38-43. PubMed ID: 19828377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A burgeoning family of biological mediators: chemokines and chemokine receptors.
    Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chapter 5. Multiple approaches to the study of chemokine receptor homo- and heterodimerization.
    Rodríguez-Frade J; Muñoz LM; Mellado M
    Methods Enzymol; 2009; 461():105-22. PubMed ID: 19480916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
    Jensen PC; Thiele S; Steen A; Elder A; Kolbeck R; Ghosh S; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2012 May; 166(1):258-75. PubMed ID: 22050085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.
    Springael JY; Le Minh PN; Urizar E; Costagliola S; Vassart G; Parmentier M
    Mol Pharmacol; 2006 May; 69(5):1652-61. PubMed ID: 16467191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor oligomerization: a pivotal mechanism for regulating chemokine function.
    Muñoz LM; Lucas P; Holgado BL; Barroso R; Vega B; Rodríguez-Frade JM; Mellado M
    Pharmacol Ther; 2011 Sep; 131(3):351-8. PubMed ID: 21600920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-evolution of proteins with their interaction partners.
    Goh CS; Bogan AA; Joachimiak M; Walther D; Cohen FE
    J Mol Biol; 2000 Jun; 299(2):283-93. PubMed ID: 10860738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.
    Kenakin T
    Trends Pharmacol Sci; 2007 Aug; 28(8):407-15. PubMed ID: 17629960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
    Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
    J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
    Thiele S; Malmgaard-Clausen M; Engel-Andreasen J; Steen A; Rummel PC; Nielsen MC; Gloriam DE; Frimurer TM; Ulven T; Rosenkilde MM
    J Med Chem; 2012 Sep; 55(18):8164-77. PubMed ID: 22957890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor antagonists: part 2.
    Pease JE; Horuk R
    Expert Opin Ther Pat; 2009 Feb; 19(2):199-221. PubMed ID: 19441918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.